Biopas is a leading and differentiated Latin American pharmaceutical company, focused on in-licensing, marketing, and selling of cutting-edge specialty pharmaceutical products.The company holds leading positions in CNS, Immunology, Dermatology, Oncology and Orphan Drugs and operates in all of LatAm with fully owned subsidiaries and more than 250 employees in Latin America.Biopas is focused on innovative and differentiated products, offering multiple therapeutic options to specialists in niche indications that cover unmet medical needs of patients. Biopas offers best in class capabilities in sales, marketing, medical, support functions and provides integral services to support the launch and development of products. All its functions operate in compliance with international standards and regulations.